Division of Pediatric Infectious Diseases

June 4, 2020

Remdesivir helps reduce COVID-19 recovery time: study

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.

By Bill Snyder
Jim Cassat, MD, PhD, and colleagues are studying enzymes involved in metabolism that are particularly important for Staphylococcus aureus to survive in host tissues.
June 3, 2020

Study explores how staph bacteria can survive in bone

A comprehensive evaluation of the metabolic pathways that support Staphylococcus aureus (“staph”) growth during invasive bone infections could offer new targets for treatment.

By Leigh MacMillan
April 29, 2020

Vanderbilt investigators encouraged by early results of placebo-controlled remdesivir trial

A preliminary look at data from hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) in a randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir is showing promising results.

By Craig Boerner
Attendees take part in last week’s online Medical Scientist Training Program seminar.
April 16, 2020

Medical Scientist Training Program adapts to COVID-19 challenges

The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19.

By Leigh MacMillan
April 9, 2020

Katz awarded LEAP Fellowship to improve antibiotic use in Tennessee

Sophie Katz, MD, MPH, is one of four early career infectious diseases physicians in the United States to receive the award, which provides $100,000 of funding support from the Centers for Disease Control and Prevention.

By Leigh MacMillan
April 6, 2020

VUMC team aids development of potential antiviral drug for COVID-19

Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

By Bill Snyder
February 5, 2020

Vaccine Program receives NIH renewal of VTEU

The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.
By Bill Snyder
January 29, 2020

Study tracks causes of high antibiotic prescribing rates in Tennessee

For a few years, Tennessee has been ranked as one of the highest antibiotic prescribing states in the nation, and a recent study showing that fewer than 2% of clinicians were responsible for prescribing 25% of pediatric antibiotics is moving some to action.
By Jessica Pasley
January 23, 2020

Vaccine Program receives NIH renewal of VTEU

The Vanderbilt Vaccine Research Program (VVRP) has received a grant from the National Institutes of Health (NIH) to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units (VTEUs).
By Bill Snyder
December 12, 2019

When should you take your child to the emergency room for cold or flu symptoms?

The majority of emergency room visits can be averted with a call or visit to a pediatrician
By Jessica Pasley
November 14, 2019

Edwards receives American Pediatric Society’s top award

Vanderbilt's Kathryn Edwards, MD, is the recipient of the 2020 John Howland Award, the highest honor given by the American Pediatric Society (APS).
By Bill Snyder
November 14, 2019

RSV transmission in the Middle East

Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.
By Laura Powell
October 9, 2019

Vaccine study seeks to halt flu’s most severe side effects

Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
By Nancy Humphrey
1 … 4 5 6 7 8 … 11